A study conducted on four COVID-19 patients with coexisting ischemic stroke has shown an elevated D-diameter (a lab test that measures fibrin degradation fragments) and C-reactive protein level (CRP, a protein produced by the liver in response to inflammation). The gene discussed is CRP; the disease is COVID-19.